Wrishko, R. E., McCrea, J. B., Yee, K. L., Liu, W., Panebianco, D., Mangin, E., . . . Kraft, W. K. (2019). Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open‑Label, Fixed-Sequence Trials in Healthy Subjects. Clin Drug Investig.
Chicago Style CitationWrishko, Rebecca E., Jacqueline B. McCrea, Ka Lai Yee, Wen Liu, Deborah Panebianco, Eric Mangin, Manu Chakravarthy, Maria P. Martinez-Cantarin, i Walter K. Kraft. "Effect of CYP3A Inhibition and Induction On the Pharmacokinetics of Suvorexant: Two Phase I, Open‑Label, Fixed-Sequence Trials in Healthy Subjects." Clin Drug Investig 2019.
Cita MLAWrishko, Rebecca E., et al. "Effect of CYP3A Inhibition and Induction On the Pharmacokinetics of Suvorexant: Two Phase I, Open‑Label, Fixed-Sequence Trials in Healthy Subjects." Clin Drug Investig 2019.